Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takahiko Kawate

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Advances in Experimental Medicine and Biology|November 18, 2017
Expression of DJ-1 in Cancer Cells: Its Correlation with Clinical SignificanceTakahiko Kawate, Benio Tsuchiya, Keiichi Iwaya
Anticancer Research|October 3, 2022
β-Tubulin Isoforms Related to Docetaxel Sensitivity in 2D and 3D Cultured TNBC Cell LinesMasako Muguruma, Mariko Asaoka, Saeko Teraoka, et al.
Histopathology|March 6, 2012
Clinical significance of DJ-1 as a secretory molecule: retrospective study of DJ-1 expression at mRNA and protein levels in ductal carcinoma of the breastBenio Tsuchiya, Keiichi Iwaya, Norio Kohno, et al.
The Journal of Surgical Research|February 25, 2020
Association of BRCA Mutations and BRCAness Status With Anticancer Drug Sensitivities in Triple-Negative Breast Cancer Cell LinesSaeko Teraoka, Masako Muguruma, Naoharu Takano, et al.
Breast Cancer Research and Treatment|April 18, 2013
DJ-1 protein expression as a predictor of pathological complete remission after neoadjuvant chemotherapy in breast cancer patientsTakahiko Kawate, Keiichi Iwaya, Ryoko Kikuchi, et al.
Breast Cancer (Tokyo, Japan)|February 20, 2021
Recommendations for the management of breast cancer patients during the COVID-19 pandemic from the Japan Breast Cancer SocietyTakahiko Kawate, Atsushi Yoshida, Sadatoshi Sugae, et al.
Cancer Diagnosis & Prognosis|July 4, 2024
Attempt to Substitute the Oncotype DX Breast Recurrence Score<sup>®</sup> Test by Histopathological Factors and MUC1 Protein ExpressionYuka Nozaki, Yoshiya Horimoto, Ryoko Semba, et al.
Biochemical and Biophysical Research Communications|September 22, 2020
Differences in drug sensitivity between two-dimensional and three-dimensional culture systems in triple-negative breast cancer cell linesMasako Muguruma, Saeko Teraoka, Kana Miyahara, et al.
Surgical Case Reports|May 12, 2025
Successful Management of Occult Breast Cancer with a Background of Anti-Melanoma Differentiation-Associated Gene 5 Antibody-Positive Interstitial Pneumonia: A Case ReportMikako Ishii, Yoshiya Horimoto, Yoichi Koyama, et al.
Breast Cancer (Tokyo, Japan)|March 7, 2024
Correlation between postoperative treatment selection and prognosis determined using the Oncotype DX® test data: a retrospective multicenter study in JapanYasue Tsuchida, Naoki Niikura, Takashi Chishima, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Advances in Experimental Medicine and Biology|November 18, 2017
Expression of DJ-1 in Cancer Cells: Its Correlation with Clinical SignificanceTakahiko Kawate, Benio Tsuchiya, Keiichi Iwaya
Anticancer Research|October 3, 2022
β-Tubulin Isoforms Related to Docetaxel Sensitivity in 2D and 3D Cultured TNBC Cell LinesMasako Muguruma, Mariko Asaoka, Saeko Teraoka, et al.
Histopathology|March 6, 2012
Clinical significance of DJ-1 as a secretory molecule: retrospective study of DJ-1 expression at mRNA and protein levels in ductal carcinoma of the breastBenio Tsuchiya, Keiichi Iwaya, Norio Kohno, et al.
The Journal of Surgical Research|February 25, 2020
Association of BRCA Mutations and BRCAness Status With Anticancer Drug Sensitivities in Triple-Negative Breast Cancer Cell LinesSaeko Teraoka, Masako Muguruma, Naoharu Takano, et al.
Breast Cancer Research and Treatment|April 18, 2013
DJ-1 protein expression as a predictor of pathological complete remission after neoadjuvant chemotherapy in breast cancer patientsTakahiko Kawate, Keiichi Iwaya, Ryoko Kikuchi, et al.
Breast Cancer (Tokyo, Japan)|February 20, 2021
Recommendations for the management of breast cancer patients during the COVID-19 pandemic from the Japan Breast Cancer SocietyTakahiko Kawate, Atsushi Yoshida, Sadatoshi Sugae, et al.
Cancer Diagnosis & Prognosis|July 4, 2024
Attempt to Substitute the Oncotype DX Breast Recurrence Score<sup>®</sup> Test by Histopathological Factors and MUC1 Protein ExpressionYuka Nozaki, Yoshiya Horimoto, Ryoko Semba, et al.
Biochemical and Biophysical Research Communications|September 22, 2020
Differences in drug sensitivity between two-dimensional and three-dimensional culture systems in triple-negative breast cancer cell linesMasako Muguruma, Saeko Teraoka, Kana Miyahara, et al.
Surgical Case Reports|May 12, 2025
Successful Management of Occult Breast Cancer with a Background of Anti-Melanoma Differentiation-Associated Gene 5 Antibody-Positive Interstitial Pneumonia: A Case ReportMikako Ishii, Yoshiya Horimoto, Yoichi Koyama, et al.
Breast Cancer (Tokyo, Japan)|March 7, 2024
Correlation between postoperative treatment selection and prognosis determined using the Oncotype DX® test data: a retrospective multicenter study in JapanYasue Tsuchida, Naoki Niikura, Takashi Chishima, et al.
Pageof 4